Good news for some hard-to-treat hepatitis C patients

ST. LOUIS -- In a multi-center trial led by a Saint Louis University researcher, investigators found that a new combination therapy of daily consensus interferon and ribavirin helps some hepatitis C patients who have not responded to previous treatment.

Read the whole article on Science Blog

More from Science Blog